Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Research and Development

Human HealthOasmia is development the next generation of drugs with focus on oncology.

Further reading »

About Oasmia

Animal HealthOasmia is a pharmaceutical company in Uppsala, Sweden with one approved product in Russia and one conditionally approved in the USA.

Further reading »

The Share

Latest News

Clarification of article in BioPharm Insight

May 11 2016
Further reading »

Change in number of shares and voting rights in Oasmia Pharmaceutical AB (publ)

April 29 2016
Further reading »

Oasmia Pharmaceutical Announces Positive Overall Survival Results from Phase III Study of Paclical/Apealea for Treatment of Ovarian Cancer

April 27 2016
Overall Survival data from the Phase III study meets endpoint and demonstrates non-inferiority favoring Paclical/Apealea; will form basis for application seeking marketing approval in the United States anticipated for the end of 2016/2017.
Further reading »